BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 13366405)

  • 1. Therapeutic effect of sulphadiazine and dihydrotriazines against blood-induced P. cynomolgy infection.
    NAIR CP; RAY AP; SINGH J
    Indian J Malariol; 1956 Jun; 10(2):131-5. PubMed ID: 13366405
    [No Abstract]   [Full Text] [Related]  

  • 2. The mode of action of sulphonamides, proguanil and pyrimethamine on Plasmodium gallinaceum.
    ROLLO IM
    Br J Pharmacol Chemother; 1955 Jun; 10(2):208-14. PubMed ID: 14389662
    [No Abstract]   [Full Text] [Related]  

  • 3. Screening of antimalarials against P. gallinaceum in chicks.
    JASWANT SINGH ; BASU PC; RAY AP
    Indian J Malariol; 1952 Jun; 6(2):145-58. PubMed ID: 13044275
    [No Abstract]   [Full Text] [Related]  

  • 4. Studies on Nuri Strain of P. knowlesi. IX. Susceptibility to sulphonamide substituted dihydrotriazine, sulphadiazine and mepacrine.
    RAY AP; NAIR CP
    Indian J Malariol; 1955 Sep; 9(3):197-202. PubMed ID: 13285915
    [No Abstract]   [Full Text] [Related]  

  • 5. Sulphadiazine-resistance in Plasmodium gallinaceum and its relation to other antimalarial compounds.
    BISHOP A; McCONNACHIE EW
    Parasitology; 1950 Jan; 40(1-2):163-74. PubMed ID: 15401181
    [No Abstract]   [Full Text] [Related]  

  • 6. Potentiation of pyrimethamine by sulphadiazine in human malaria.
    HURLY MG
    Trans R Soc Trop Med Hyg; 1959 Sep; 53():412-3. PubMed ID: 14405526
    [No Abstract]   [Full Text] [Related]  

  • 7. Studies on Plasmodium berghei Vincke and Lips, 1948. XXIX. The size of parasite population and its relation to the selection of a strain resistant to sulphadiazine.
    RAMAKRISHNAN SP; PRAKASH S; CHOWDHURY DS; BASU PC
    Indian J Malariol; 1961 Jun; 15():95-106. PubMed ID: 14490070
    [No Abstract]   [Full Text] [Related]  

  • 8. Potentiation of the antimalarial activity of sulfadiazine by 2,4-diamino-5-aryloxypyrimidines.
    GREENBERG J; RICHESON EM
    J Pharmacol Exp Ther; 1950 Aug; 99(4:1):444-9. PubMed ID: 15437322
    [No Abstract]   [Full Text] [Related]  

  • 9. [Further development of the Roehl test for testing antimalarial agents on Plasmodium cathemerium in the canary by intravenous administration].
    Fink E; Dann O
    Z Tropenmed Parasitol; 1967 Dec; 18(4):466-74. PubMed ID: 5613461
    [No Abstract]   [Full Text] [Related]  

  • 10. The effect of sulphadiazine, proguanil and 2:4-diamino-6:7-diisopro-Pylpteridine upon gametocyte production in Plasmodium gallinaceum (Brumpt, 1935).
    BISHOP A
    Parasitology; 1954 May; 44(1-2):120-31. PubMed ID: 13166378
    [No Abstract]   [Full Text] [Related]  

  • 11. Toxoplasmic uveitis; treatment with pyrimethamine and sulfadiazine.
    BEUERMAN VA; BURNHAM CJ
    Am J Ophthalmol; 1956 Aug; 42(2):217-27. PubMed ID: 13354693
    [No Abstract]   [Full Text] [Related]  

  • 12. The effect of metabolites on the antitoxoplasmic action of pyrimethamine and sulfadiazine.
    EYLES DE; COLEMAN N
    Am J Trop Med Hyg; 1960 May; 9():277-83. PubMed ID: 13821130
    [No Abstract]   [Full Text] [Related]  

  • 13. The chemotherapy of rodent malaria. VII. The action of some sulphonamides alone or with folic reductase inhibitors against malaria vectors and parasites, 2: schizontocidal action in the albino mouse.
    Peters W
    Annu Rev Pharmacol; 1968 Dec; 62(4):488-94. PubMed ID: 5731727
    [No Abstract]   [Full Text] [Related]  

  • 14. Relative reversal by vitamins (rho-aminobenzoic, folic, and folinic acids) of the effects of sulfadiazine and pyrimethamine on Toxoplasma, mouse and man.
    FRENKEL JK; HITCHINGS GH
    Antibiot Chemother (Northfield); 1957 Dec; 7(12):630-8. PubMed ID: 24544594
    [No Abstract]   [Full Text] [Related]  

  • 15. Sulphonamides and folic acid antagonists in malaria and toxoplasmosis.
    GOODWIN LG
    Proc R Soc Med; 1956 Nov; 49(11):871-3. PubMed ID: 13379419
    [No Abstract]   [Full Text] [Related]  

  • 16. Efficacy and safety of atovaquone-proguanil in treating imported malaria in Japan: the second report from the research group.
    Kimura M; Koga M; Kikuchi T; Miura T; Maruyama H
    Parasitol Int; 2012 Sep; 61(3):466-9. PubMed ID: 22484597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atovaquone/proguanil: a review of its use for the prophylaxis of Plasmodium falciparum malaria.
    McKeage K; Scott L
    Drugs; 2003; 63(6):597-623. PubMed ID: 12656656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Tolerance and efficacy of atovaquone-proguanil for the treatment of paediatric imported Plasmodium falciparum malaria in France: clinical practice in a university hospital in Paris].
    Blondé R; Naudin J; Bigirimana Z; Holvoet L; Fenneteau O; Vitoux C; Bourdon O; Angoulvant F; Lorrot M; D'Ortenzio E; Bourrillon A; Le Bras J; Matheron S; Faye A
    Arch Pediatr; 2008 Mar; 15(3):245-52. PubMed ID: 18321692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies in human malaria; the suppressive action of sulfadiazine and sulfapyrazine against sporozoite-induced vivax malaria (St. Elizabeth strain).
    COATNEY GR; COOPER WC
    Am J Hyg; 1947 Jul; 46(1):105-18. PubMed ID: 20252852
    [No Abstract]   [Full Text] [Related]  

  • 20. Resistance to sulphadiazine and paludrine in the malaria parasite of the fowl, P. gallinaceum.
    BISHOP A; McCONNACHIE EW
    Nature; 1948 Oct; 162(4118):541-3. PubMed ID: 18884622
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.